Efficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm Study

INTRODUCTION: Patients with mild-to-moderate plaque psoriasis often experience reduced quality of life and increased disease burden due to itch or involvement of psoriasis in special areas such as the scalp and nails. Systemic therapy may be used concurrently with topical therapy in patients with ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Okubo, Yukari, Takahashi, Hidetoshi, Hino, Ryosuke, Endo, Koki, Kikuchi, Satoru, Ozeki, Yasushi, Nakamura, Taichi, Paris, Maria, Abe, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209617/
https://www.ncbi.nlm.nih.gov/pubmed/35689737
http://dx.doi.org/10.1007/s13555-022-00747-5

Ejemplares similares

Ejemplares similares